FDA Misses Deadline to Define Key Hemp Terms as November Ban Looms
The FDA missed its deadline to define key terms under the November hemp ban. Here's what that means for your business.
We've written before about the difference between a bill and a law, and why the industry shouldn't plan around legislative proposals that may never pass. The FDA just gave everyone another reason to pay attention to that distinction.
The agency was given 90 days under the appropriations legislation President Trump signed last year to publish guidance that would shape how the November hemp ban gets implemented. That deadline was February 10, 2026, and FDA didn't deliver.
What FDA Was Supposed to Publish
The spending bill required FDA to release:
- A list of all cannabinoids known to be naturally produced by cannabis
- A list of all THC-class cannabinoids naturally occurring in the plant
- A list of all cannabinoids with "similar effects" to THC, or marketed as having similar effects
- Clarification on what "container" means for per-serving THC limits
An HHS spokesperson told Marijuana Moment the agency intended to meet the deadline, but nothing has appeared in the Federal Register.
Why the "Container" Definition Matters
The spending bill caps legal hemp products at 0.4 milligrams of total THC per "container," but the law's definition of that term is broad enough to create real ambiguity. It refers to "the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product"—which could mean a single gummy, a bag of gummies, a jar, a cartridge, or something else entirely.
How FDA interprets that term will determine whether entire product categories can continue to exist legally. A strict interpretation could eliminate most consumable products on the market. A more permissive reading might preserve some product formats. Until FDA publishes its guidance, businesses have no way to plan for compliance because they don't know what compliance looks like.
The Cannabinoid Lists Create Similar Uncertainty
The November ban shifts enforcement from delta-9 THC to total THC, which includes delta-8 and other isomers. It also covers "any other cannabinoids that have similar effects (or are marketed to have similar effects)" to THC.
That phrase does a lot of work, and FDA's lists were supposed to clarify which cannabinoids fall into that category. Without those lists, manufacturers and retailers are left guessing about which products will be considered compliant and which will be treated as prohibited substances.
What This Means for the Delay Effort
Industry advocates are pointing to this missed deadline as evidence that Congress needs to pass the Hemp Planting Predictability Act or similar legislation to push back the November implementation date.
"There is a whole lot of work to do, and the FDA is going to be in the middle of this, and there's not enough time to come up with a thought-out regulatory regime to replace the ban," Jonathan Miller, general counsel of the U.S. Hemp Roundtable, told Marijuana Moment.
He's not wrong about the timeline problem, but as we've noted before, the delay bill is a proposal, not a promise. FDA missing a deadline might strengthen the argument for an extension, but arguments don't move legislation through committee. The ban is still law, and the delay is still just a bill sitting in a stack.
What Hemp Operators Should Do Now
The regulatory landscape is unstable, but that doesn't mean you're powerless.
Document your compliance efforts.
If enforcement actions come, a clear compliance record matters for your defense.
Monitor state-level requirements.
Federal chaos doesn't pause state obligations, and you still need to stay current with your state's regulatory framework. Tennessee's protections for licensed retailers selling THCa flower under 0.3% delta-9 still expire June 30, 2026, regardless of what happens at the federal level.
Plan for multiple scenarios.
The November ban may hold, may be delayed, or may be replaced with a new regulatory framework, and your business strategy should account for all three possibilities.
Hemp Law Group is tracking these developments closely. If you have questions about how this affects your specific operation, or if you need help preparing for what's coming, schedule a consultation with Compliance Director Clint Palmer below.
This article is for informational purposes only and does not constitute legal advice. Hemp regulations vary by state and change frequently. Consult with a qualified attorney for guidance specific to your situation.
Ready to protect your hemp business?
Let’s ensure your compliance and legal needs are covered.
